Breast and Gynecologic Warning Signs: Symptoms to Check Between Screenings

Screening and symptom evaluation are different

Mammograms and cervical tests are designed to look for disease before symptoms develop. A new symptom needs its own evaluation even when the next screening is not due. Most breast or pelvic symptoms have explanations other than cancer, but that is a reason for an orderly assessment, not a reason to ignore a change. PR43 PR62

When calling the office, say that you have a new symptom. “I found a new lump” is more useful for triage than “I need my yearly mammogram.” “I have bleeding after menopause” conveys something different from “I need a routine Pap test.” The distinction helps the office arrange the right appointment and test.

Breast changes to report

Arrange evaluation for a new lump or thickening in the breast or underarm, new nipple changes, unexpected nipple discharge, persistent skin dimpling or swelling, or a change in breast shape. Persistent focal pain also deserves a discussion, although many causes of breast pain are not cancer. Report a new change even after a recent normal mammogram. PR43

Being familiar with your usual breast appearance can help you notice changes. A rigid monthly self-examination routine has not been shown to reduce breast-cancer deaths and does not replace mammography. The practical goal is to notice and report a change, not to become responsible for diagnosing it yourself. PR44

Evaluation may involve examination, diagnostic mammography, ultrasound, or biopsy, depending on age and the finding. A callback after screening is not the same as a cancer diagnosis. Ask what the next test is intended to clarify and when it should occur. PR43 PR64

Bleeding after menopause needs prompt assessment

Once menstrual periods have stopped for 12 months because of menopause, unexpected vaginal bleeding or spotting should be evaluated. Mention whether you use hormone therapy or blood thinners, but do not assume those medicines fully explain the bleeding. If bleeding is heavy or comes with faintness or serious illness, use urgent or emergency care. PR46

ACOG updated its guidance in April 2026: most patients with postmenopausal bleeding should have both transvaginal ultrasound and a sample of the uterine lining in the initial evaluation. Ultrasound alone may be reasonable in selected low-risk patients with a first episode, a fully seen thin lining, and reliable prompt follow-up. Continued or recurrent bleeding requires reassessment. A reassuring scan should not become a permanent reason to dismiss new bleeding. PR58

For women still having periods, persistent bleeding between periods, bleeding after sex, or a marked change in bleeding also deserves evaluation. The need for sampling or other tests depends on age, history, and risk. A Pap test is not a general screening test for cancer of the uterine lining. PR46 PR47

What to know about ovarian cancer concerns

Persistent or worsening bloating, pelvic or abdominal pressure, feeling full unusually quickly, or a new ongoing change in urinary or bowel habits should be discussed. These symptoms are nonspecific and often have other causes. Their persistence, progression, and effect on daily life matter. There is no single symptom checklist that can diagnose or exclude ovarian cancer. PR45

Routine CA-125 tests and pelvic ultrasound are not recommended as screening for average-risk women without symptoms. The same tests may have a role when evaluating an actual symptom or a concerning finding. Screening a healthy person and investigating a problem are different medical decisions. PR45

A positive HPV result is not a cancer diagnosis

An HPV test identifies certain high-risk virus types; a Pap test examines cervical cells. A positive HPV result may lead to closer follow-up, more testing, or colposcopy depending on the type detected and previous results. An abnormal Pap result often reflects changes that can be watched or treated before cancer develops. PR61 PR62

HPV can become detectable years after an earlier exposure, so a new positive test does not establish when an infection was acquired or prove a partner has been unfaithful. Focus on the medical follow-up. HPV vaccination does not remove the need for the appropriate screening plan. PR63 PR62

If you self-collected an HPV sample, an abnormal result may still require an in-person cervical examination or additional clinician-collected testing. Ask exactly what result was found and what the next step is. Do not interpret the words “positive” or “abnormal” in isolation.

Family history can change the whole pathway

Tell your clinician about breast, ovarian, fallopian-tube, and related cancers in both your mother's and father's families. Include male breast cancer and relatives diagnosed young. USPSTF recommends a brief inherited-risk assessment when the personal or family history or ancestry suggests a BRCA-related risk, followed by genetic counseling and testing when indicated. PR48

Genetic counseling can clarify which test is useful, whether testing an affected relative first would be more informative, and what a result might change. A consumer genetic result should not replace a clinical assessment of a concerning family history. If there is a known family mutation, bring the actual report when possible.

Make sure the result has an owner

Keep copies of important reports and a list of next steps. Before leaving, ask who will contact you, how long results usually take, and whom to call if they do not arrive. If a biopsy, imaging study, or specialist appointment is recommended, ask whether the office will track completion. An unclear result is a reason to obtain an explanation, not to assume that silence means everything is normal.

Questions to bring: Is this screening or a diagnostic test? What does the result actually mean? Is a biopsy needed? What should happen if symptoms persist despite a normal test? Does my family history justify genetic counseling? Who is responsible for closing the follow-up loop?